Plasma Cell Disorders

Plasma cell disorders are characterized by the clonal proliferation of plasma cells producing abnormal immunoglobulins. These conditions range from asymptomatic precursor states to aggressive malignancies. Clinical manifestations include anemia, bone lesions, renal impairment, infections, and hypercalcemia. Diagnosis involves laboratory evaluation of monoclonal proteins, bone marrow examination, imaging studies, and cytogenetic analysis. Risk stratification and disease monitoring are critical components of management. Treatment strategies have evolved significantly with the introduction of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and stem cell transplantation. Precision medicine approaches are increasingly applied to tailor therapy based on genetic and molecular features. Research continues to focus on early detection, treatment optimization, resistance mechanisms, and curative strategies. Plasma cell disorders represent a rapidly advancing area of hematology with substantial translational and clinical research impact.